HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge A Martínez-Escribano Selected Research

HLA-A Antigens (HLA-A)

1/2006HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge A Martínez-Escribano Research Topics

Disease

7Melanoma (Melanoma, Malignant)
05/2013 - 03/2005
2Disease Susceptibility (Diathesis)
05/2013 - 01/2006
2Cutaneous Malignant Melanoma
05/2013 - 01/2006
2Vitiligo
01/2007 - 01/2005
1Acquired Immunodeficiency Syndrome (AIDS)
01/2007
1Exfoliative Dermatitis (Erythroderma)
01/2007
1Disease Progression
08/2006
1Neoplasm Metastasis (Metastasis)
01/2006
1Neoplasms (Cancer)
03/2005

Drug/Important Bio-Agent (IBA)

3HLA-C Antigens (HLA-C)IBA
05/2013 - 01/2006
2LigandsIBA
05/2013 - 08/2006
2Type 1 Melanocortin ReceptorIBA
08/2010 - 05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009
1Nevirapine (Viramune)FDA Link
01/2007
1PerforinIBA
01/2007
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2006
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2006
1OligonucleotidesIBA
01/2006
1HLA-A Antigens (HLA-A)IBA
01/2006
1HLA-B Antigens (HLA-B)IBA
01/2006
1HLA-DQB1 antigen (HLA DQB1)IBA
01/2006
1CytokinesIBA
03/2005
1Interleukin-15 (Interleukin 15)IBA
03/2005
1Interleukin-6 (Interleukin 6)IBA
03/2005
1Interleukin-10 (Interleukin 10)IBA
03/2005
1Infliximab (Remicade)FDA Link
01/2005

Therapy/Procedure

1Therapeutics
08/2006